Drug details
Alunbrig (brigatinib tablets)
type of Antineoplastics, Anaplastic Lymphoma Kinase Inhibitors
Alunbrig (brigatinib) is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on, or are intolerant to, crizotinib.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- fever,
- lightheadedness,
- confusion,
- chest pain,
- dizziness,
- severe headache,
- blurred vision,
- pounding in your neck or ears,
- weakness,
- cough,
- increased thirst,
- increased urination,
- fruity breath odor,
- trouble breathing,
- hunger,
- double vision,
- increased sensitivity to light,
- seeing flashes of light or “floaters” in your vision,
- very slow heartbeats,
- unexplained muscle pain or weakness,
- upper stomach pain (worse with eating and may spread to your back), and
- weight loss
The following drugs are related to Alunbrig, either as a replacement or used together:
- Krazati (adagrasib tablets)
- Proleukin (aldesleukin for injection)
- Vegzelma (bevacizumab-adcd injection)
- BiCNU (carmustine)
- Blenoxane (bleomycin sulfate injection)
- Camptosar Injection (irinotecan hydrochloride)
- CeeNU (lomustine capsules)
- Cosela (trilaciclib for injection)
- Vizimpro (dacomitinib)
- Taxotere (docetaxel for injection)
- Elzonris (tagraxofusp-erzs injection)
- Tarceva (erlotinib)
- Etopophos (etoposide phosphate)
- VePesid (etoposide)
- Exkivity (mobocertinib capsules)
- Iressa (gefitinib)
- Genotropin (somatropin [rdna origin])
- Herceptin (trastuzumab)
- Humatrope (somatropin rdna origin)
- Vitrakvi (larotrectinib capsules)
- Zepzelca (lurbinectedin for injection)
- Nilandron (nilutamide tablets)
- Udenyca (pegfilgrastim-cbqv injection)
- Turalio (pexidartinib capsules)
- Rapamune (sirolimus)
- Rituxan (rituximab)
- Tepmetko (tepotinib tablets)